PORRO MASSIMO has a total of 11 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are SYLVAN PHARMACEUTICALS PTY LTD, OPKO BIOLOG LTD and REMD BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Finland | 1 | |
#6 | Ireland | 1 | |
#7 | Israel | 1 | |
#8 | New Zealand | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Polysaccharides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Porro Massimo | 9 |
#2 | Massimo Porro | 2 |
Publication | Filing date | Title |
---|---|---|
WO03094961A1 | Improved polysaccharide and glycoconjugate vaccines_____________ | |
ZA9200943B | Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |